What's new: Beijing and several other Chinese cities have started offering residents China's first Covid-19 vaccine against four variants of the virus, as the country speeds up its vaccination drive to tackle a growing wave of infections. The four-valent Covid vaccine, SCTV01E, is a recombinant protein vaccine developed by Beijing-based drugmaker Sinocelltech Group Ltd. It offers 'better broad-spectrum protection' against the main variants identified by the World Health Organization — alpha, beta, delta and omicron, a researcher at the company said in a Beijing Daily report.

https://www.caixinglobal.com/2023-05-29/china-rolls-out-its-first-four-valent-covid-vaccine-as-infections-spike-102059997.html

#caixinglobal